Clinical Trial Update: Synergetic B-cell Immodulation in SLE [Phase 2]

View source ↗

Summary

Phase 2 trial update for a B-cell modulation approach in systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Leiden University Medical Center | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED